It’s no secret that Bristol-Myers Squibb’s investors are feeling skittish after a pair of negative Opdivo developments last week. And on Thursday’s third-quarter conference call, executives plunged right into their doubts. After a two-day period in which the company 1) saw competitive kidney cancer data posted by Opdivo archrival Keytruda from Merck and 2) produced… Read More »
When I discovered about my fatty liver disease, or hepatic steatosis, I thought that there was no treatment that could aid. Fatty liver disease results from excessive fat (triglycerides) build up in the liver. If left untreated, this can lead to liver cancer, cirrhosis, and worst, liver failure. I was thus very eager to uncover… Read More »
Hope you enjoyed todays video! If you enjoyed it at any point be sure to subscribe and follow me on twitter to interact with me 🙂 hey guys dont ever do xanax i hope you learn for this experience that i had and i hope you also enjoyed this new story about the first time… Read More »